The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?

① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.

cls.cnJan 2 16:20

As the Spring Festival holiday approaches, the tourism Industry is expected to pick up, and these Concept stocks are frequently being investigated.

The Spring Festival holiday is from January 28 to February 4, 2025, totaling 8 days.

cls.cnDec 20, 2024 08:45

Chat records, dual contracts? Xiangcai Co., Ltd. announced clarifications, involving three key points.

① Xiangcai Co., Ltd stated that neither the company nor its subsidiaries have signed hidden contracts with related parties, nor have they provided assistance for related illegal activities. ② The subsidiaries have also conducted various self-inspections and verifications, and have not found that Xiangcai Securities or its staff provided assistance for related illegal activities.

cls.cnDec 8, 2024 21:15

Old case with new twists: Yunnan reits won 0.342 billion in the first trial ruling, how likely is a success in the retrial?

① This judgment is a first-instance judgment and has not yet taken effect. Xiangcai Securities is actively preparing for an appeal; ② The company plans to make provisions for estimated liabilities based on the first-instance judgment, with the specific amount pending confirmation from the annual auditor's audit results.

cls.cnDec 3, 2024 22:06

Suzhou's 40 billion AIC fund is taking action! It plans to invest in 10 projects, with a preference for the commercial aerospace sector.

①Currently, there are 5 AIC funds established in Suzhou, with a total size of 40 billion yuan, mainly funded by banks, Suzhou municipal state-owned assets, and district-level state-owned assets. ②Commercial aviation-related projects are particularly favored by the Suzhou AIC Fund, with 3 out of the 5 funds investing in projects in this field, involving projects such as Tianbing Aviation, Dianshi Aviation, and Aerospace Times Feipeng.

cls.cnNov 28, 2024 18:37

When will the company turn losses around is questioned, tonghua dongbao mentioned that sales of insulin analogs have increased slightly | Live coverage of the earnings conference

① During the earnings conference, an investor asked when tonghua dongbao pharmaceutical would be able to emerge from its losses. Chairman Li Jiahong expressed optimism that the company's performance is expected to further recover and grow; ② With the continued implementation of the Q3 insulin centralized procurement across provinces and cities, the sales volume of the company's insulin analogs has doubled; ③ During the earnings conference, the company also addressed issues like the increase in selling expenses and the slow progress of capitalizing construction projects.

cls.cnNov 18, 2024 20:49